Applicability of current prognostication models for MDS patients with DDX41 mutationNadia Toumeh, Aref Al‐Kali, Antoine N. Saliba et al.|Leukemia Research|2025Cited by 2
Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatmentOudai Alkabbani, Aref Al‐Kali, Yazan Jabban et al.|Haematologica|2025Cited by 0
Insights into clonal and CBC changes at disease evolution among ccus patientsYazan Jabban, Aref Al‐Kali, Rong He et al.|Blood|2025Cited by 0
Distinct advantages for risk scoring models in patients with clonal cytopenia of undetermined significanceYazan Jabban, Aref Al‐Kali, Rong He et al.|British Journal of Haematology|2026Cited by 0
Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significanceYazan Jabban, Aref Al-Kali, Rong He et al.|Haematologica|2026Cited by 0